JP2023503850A5 - - Google Patents

Info

Publication number
JP2023503850A5
JP2023503850A5 JP2022527987A JP2022527987A JP2023503850A5 JP 2023503850 A5 JP2023503850 A5 JP 2023503850A5 JP 2022527987 A JP2022527987 A JP 2022527987A JP 2022527987 A JP2022527987 A JP 2022527987A JP 2023503850 A5 JP2023503850 A5 JP 2023503850A5
Authority
JP
Japan
Prior art keywords
vector construct
c1ei
composition
functional
construct according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022527987A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023503850A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/060337 external-priority patent/WO2021097157A1/en
Publication of JP2023503850A publication Critical patent/JP2023503850A/ja
Publication of JP2023503850A5 publication Critical patent/JP2023503850A5/ja
Pending legal-status Critical Current

Links

JP2022527987A 2019-11-14 2020-11-13 肝臓特異的遺伝子療法ベクターによる遺伝性血管浮腫の治療 Pending JP2023503850A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962935359P 2019-11-14 2019-11-14
US62/935,359 2019-11-14
US202063016365P 2020-04-28 2020-04-28
US63/016,365 2020-04-28
PCT/US2020/060337 WO2021097157A1 (en) 2019-11-14 2020-11-13 Treatment of hereditary angioedema with liver-specific gene therapy vectors

Publications (2)

Publication Number Publication Date
JP2023503850A JP2023503850A (ja) 2023-02-01
JP2023503850A5 true JP2023503850A5 (cg-RX-API-DMAC7.html) 2023-11-20

Family

ID=73834586

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022527987A Pending JP2023503850A (ja) 2019-11-14 2020-11-13 肝臓特異的遺伝子療法ベクターによる遺伝性血管浮腫の治療

Country Status (14)

Country Link
US (1) US20230340078A1 (cg-RX-API-DMAC7.html)
EP (1) EP4058475A1 (cg-RX-API-DMAC7.html)
JP (1) JP2023503850A (cg-RX-API-DMAC7.html)
KR (1) KR20220098210A (cg-RX-API-DMAC7.html)
CN (1) CN114829391A (cg-RX-API-DMAC7.html)
AU (1) AU2020384294A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022009279A2 (cg-RX-API-DMAC7.html)
CA (1) CA3161154A1 (cg-RX-API-DMAC7.html)
CL (1) CL2022001260A1 (cg-RX-API-DMAC7.html)
CO (1) CO2022005641A2 (cg-RX-API-DMAC7.html)
IL (1) IL292717A (cg-RX-API-DMAC7.html)
MX (1) MX2022005869A (cg-RX-API-DMAC7.html)
TW (1) TW202128733A (cg-RX-API-DMAC7.html)
WO (1) WO2021097157A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230078805A (ko) 2020-11-02 2023-06-02 바이오마린 파머수티컬 인크. 아데노-연관 바이러스의 농축 공정
KR20230136147A (ko) * 2021-01-27 2023-09-26 스파크 테라퓨틱스, 인코포레이티드 유전성 혈관부종을 치료하기 위한 조성물 및 방법
BR112023026523A2 (pt) * 2021-06-17 2024-03-05 Meiragtx Uk Ii Ltd Métodos para fabricar aav
TW202332472A (zh) 2021-10-01 2023-08-16 美商拜奧馬林製藥公司 利用aav基因療法載體進行之遺傳性血管水腫治療及治療性調配物
CN117947040A (zh) 2022-10-31 2024-04-30 苏州荷光科汇生物科技有限公司 用于目的基因的表达盒及其应用
US20260207786A1 (en) * 2024-11-18 2026-07-23 Sonothera, Inc. Methods and compositions for improved delivery via ultrasound

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0127839B1 (en) 1983-05-27 1992-07-15 THE TEXAS A&M UNIVERSITY SYSTEM Method for producing a recombinant baculovirus expression vector
US4745051A (en) 1983-05-27 1988-05-17 The Texas A&M University System Method for producing a recombinant baculovirus expression vector
DK518384A (da) 1984-01-31 1985-07-01 Idaho Res Found Vektor til fremstilling af et gen-produkt i insektceller, fremgangsmaade til dens fremstilling samt dens anvendelse
US6204059B1 (en) 1994-06-30 2001-03-20 University Of Pittsburgh AAV capsid vehicles for molecular transfer
US7323324B2 (en) 2001-10-16 2008-01-29 National Institute Of Advanced Industrial Science And Technology N-Acetylglucosamine transferase, nucleic acid encoding the same, antibody against the same and use thereof for diagnosing cancer or tumor
US6723551B2 (en) 2001-11-09 2004-04-20 The United States Of America As Represented By The Department Of Health And Human Services Production of adeno-associated virus in insect cells
CN103589692B (zh) 2001-11-13 2018-07-24 宾夕法尼亚大学托管会 检测和/或鉴定腺伴随病毒(aav)序列以及分离所鉴定的新型序列的方法
WO2003074714A1 (en) 2002-03-05 2003-09-12 Stichting Voor De Technische Wetenschappen Baculovirus expression system
AU2003221733A1 (en) * 2002-04-17 2003-11-03 University Of Florida Research Foundation, Inc. Improved raav vectors
US7943379B2 (en) 2008-04-30 2011-05-17 Nationwide Children's Hospital, Inc. Production of rAAV in vero cells using particular adenovirus helpers
BR112014020325A2 (pt) 2012-02-17 2017-08-08 Childrens Hospital Philadelphia composições de vetor do aav e métodos para a transferência de gene para as células, órgãos e tecidos
NZ716102A (en) * 2013-07-22 2021-12-24 The Children’S Hospital Of Philadelphia Variant aav and compositions, methods and uses for gene transfer to cells, organs and tissues
ES2813698T3 (es) * 2013-09-12 2021-03-24 Biomarin Pharm Inc Vectores de AAV que comprenden un gen que codifica el factor VIII
KR20180014051A (ko) * 2015-05-28 2018-02-07 코넬 유니버시티 혈관 부종 치료제로서의 아데노-관련 바이러스 매개 c1e1의 전달
JP6994018B2 (ja) 2016-07-26 2022-01-14 バイオマリン ファーマシューティカル インコーポレイテッド 新規アデノ随伴ウイルスキャプシドタンパク質
EP3740581A4 (en) * 2018-01-16 2021-10-27 CLS Therapeutics Limited TREATMENT OF DISEASES BY LIVER EXPRESSION OF AN ENZYME WITH DESOXYRIBONUCLEASE (DNASE) ACTIVITY
JP2022505876A (ja) * 2018-10-26 2022-01-14 フリーイェ・ユニヴェルシテイト・ブリュッセル 遺伝子治療を向上させる新しいツール及びその使用
WO2021081280A1 (en) * 2019-10-23 2021-04-29 Shire Human Genetic Therapies, Inc. Adeno-associated virus vectors based gene therapy for hereditary angioedema

Similar Documents

Publication Publication Date Title
US20220331409A1 (en) Factor ix gene therapy
US20240109938A1 (en) Recombinant aav1, aav5, and aav6 capsid mutants and uses thereof
US10308957B2 (en) rAAV vectors and methods for transduction of photoreceptors and RPE cells
US11338045B2 (en) Adeno-associated virus vector delivery of a fragment of micro-dystrophin to treat muscular dystrophy
US12612432B2 (en) AAV capsid variants for gene therapy
SG11202111400TA (en) Compositions useful for treatment of pompe disease
US20240102050A1 (en) Compositions and methods for treatment of neurological disorders
EP3773748A1 (en) Bicistronic aav vectors encoding hexosaminidase alpha and beta-subunits and uses thereof
CA3207268A1 (en) Compositions and methods for treating hereditary angioedema
WO2021231575A1 (en) Immunosuppressive agents and viral delivery re-dosing methods for gene therapy
Chen Adeno-associated virus vectors for human gene therapy
US11517631B2 (en) Factor IX encoding nucleotides
US12274757B2 (en) Recombinant adeno-associated viruses encoding serpin peptides and uses thereof
US20250144243A1 (en) Aav capsids for improved heart transduction and detargeting of liver
EP4684808A1 (en) Plasmids, transgenes, vectors and medical uses comprising adamts13
US12583907B2 (en) Modified plasma clotting factor VIII and method of use thereof
US20240076691A1 (en) Codon-optimized nucleic acid encoding the fix protein
JP2024511851A (ja) 改変血漿凝固第viii因子およびその使用方法
OA21369A (en) Codon-optimized nucleic acid encoding the fix protein.
Mcintosh et al. Factor VIII sequences
GB2576508A (en) Factor IX encoding nucleotides